| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +42.99% | +0.87% | +42.12% | +42.12% | — |
| 14d | 1 | +100.00% | +34.82% | +2.19% | +32.63% | +32.63% | — |
| 30d | 1 | +100.00% | +16.45% | -0.09% | +16.54% | +16.54% | — |
| 60d | 1 | +100.00% | +7.96% | +1.92% | +6.04% | +6.04% | — |
| 90d | 1 | +100.00% | +5.10% | +3.59% | +1.50% | +1.50% | — |
| 180d | 1 | +0.00% | -9.13% | +0.50% | -9.63% | -9.63% | — |
| 1y | 1 | +100.00% | +96.71% | +11.72% | +84.99% | +84.99% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IMNM IMMUNOME INC. | SALE10b5-1 10b5-1 plan | 14,420 | $20.66 | $297.9K | 15,805 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE10b5-1 10b5-1 plan | 40,580 | $19.56 | $793.7K | 30,225 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Medical Officer | 55,000 | $8.73 | $480.1K | 70,805 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE Chief Medical Officer | 55,000 | — | — | 345,000 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 242,000 | — | — | 242,000 | Jul 29, 2025 | Jul 31, 2025 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Medical Officer | 15,805 | $9.48 | $149.8K | 15,805 | Nov 21, 2024 | Nov 21, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Aug 9, 2024 | Aug 13, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Oct 27, 2023 | Oct 31, 2023 ↗ | View → |